These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 10515817

  • 1. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants.
    Yu X, Gray B, Chang S, Ward JI, Edwards KM, Nahm MH.
    J Infect Dis; 1999 Nov; 180(5):1569-76. PubMed ID: 10515817
    [Abstract] [Full Text] [Related]

  • 2. Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants.
    Väkeväinen M, Eklund C, Eskola J, Käyhty H.
    J Infect Dis; 2001 Sep 15; 184(6):789-93. PubMed ID: 11517443
    [Abstract] [Full Text] [Related]

  • 3. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B.
    Saeland E, Jakobsen H, Ingolfsdottir G, Sigurdardottir ST, Jonsdottir I.
    J Infect Dis; 2001 Jan 15; 183(2):253-260. PubMed ID: 11110649
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J, Tejedor JC, Grunert D, Konior R, Garcia-Sicilia J, Knuf M, Bernard L, Dieussaert I, Schuerman L.
    Pediatr Infect Dis J; 2009 Apr 15; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA, Rijkers GT, Voorhorst-Ogink MM, Zegers BJ, Sanders LA.
    J Infect Dis; 1999 May 15; 179(5):1152-6. PubMed ID: 10191217
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus.
    Dagan R, Givon-Lavi N, Fraser D, Lipsitch M, Siber GR, Kohberger R.
    J Infect Dis; 2005 Aug 01; 192(3):367-76. PubMed ID: 15995949
    [Abstract] [Full Text] [Related]

  • 13. Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial.
    Ekström N, Väkeväinen M, Verho J, Kilpi T, Käyhty H.
    Infect Immun; 2007 Apr 01; 75(4):1794-800. PubMed ID: 17261612
    [Abstract] [Full Text] [Related]

  • 14. Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children.
    Henckaerts I, Durant N, De Grave D, Schuerman L, Poolman J.
    Vaccine; 2007 Mar 22; 25(13):2518-27. PubMed ID: 17034907
    [Abstract] [Full Text] [Related]

  • 15. Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants.
    Choo S, Zhang Q, Seymour L, Akhtar S, Finn A.
    J Infect Dis; 2000 Oct 22; 182(4):1260-3. PubMed ID: 10979930
    [Abstract] [Full Text] [Related]

  • 16. Serum IgM antibodies contribute to high levels of opsonophagocytic activities in toddlers immunized with a single dose of the 9-valent pneumococcal conjugate vaccine.
    Simell B, Nurkka A, Ekström N, Givon-Lavi N, Käyhty H, Dagan R.
    Clin Vaccine Immunol; 2012 Oct 22; 19(10):1618-23. PubMed ID: 22875604
    [Abstract] [Full Text] [Related]

  • 17. Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media.
    Jokinen JT, Ahman H, Kilpi TM, Mäkelä PH, Käyhty MH.
    J Infect Dis; 2004 Aug 01; 190(3):545-50. PubMed ID: 15243930
    [Abstract] [Full Text] [Related]

  • 18. Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model.
    Skinner JM, Indrawati L, Cannon J, Blue J, Winters M, Macnair J, Pujar N, Manger W, Zhang Y, Antonello J, Shiver J, Caulfield M, Heinrichs JH.
    Vaccine; 2011 Nov 08; 29(48):8870-6. PubMed ID: 21964055
    [Abstract] [Full Text] [Related]

  • 19. Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae.
    Nahm MH, Olander JV, Magyarlaki M.
    J Infect Dis; 1997 Sep 08; 176(3):698-703. PubMed ID: 9291318
    [Abstract] [Full Text] [Related]

  • 20. Immune response in infants to the heptavalent pneumococcal conjugate vaccine against vaccine-related serotypes 6A and 19A.
    Lee H, Nahm MH, Burton R, Kim KH.
    Clin Vaccine Immunol; 2009 Mar 08; 16(3):376-81. PubMed ID: 19144787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.